Upcoming webinar on “Overcoming Resistance” led by Michael Wick – The START Center for Cancer Research

The START Center for Cancer Research shared on LinkedIn:       .

“Don’t miss our upcoming webinar, “Overcoming Resistance: Enhancing CDK4/6 Inhibitor Efficacy in Advanced Breast Cancer Treatment”, on July 9th at 3 PM ET.

Led by Michael Wick, Chief Scientific Officer at XenoSTART, this session will cover:
– Key insights into FDA-approved CDK4/6 inhibitors
– Mechanisms of resistance in ER+ breast cancer
– Strategies for re-sensitizing resistant patients through combination therapy

Register today.”

Source: The START Center for Cancer Research/LinkedIn